🔎 Trials Near Me

Hjem › KOL › Idaho

KOL kliniske forsøg i Idaho

4 studier for KOL søger deltagere på steder i Idaho.

Byer i Idaho

Officiel studietekst (engelsk)

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Meridian
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06883305

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Boise
RekruttererFase 3
Alder 40 til 75 · Alle køn · Opdateret 28. jul. 2026 · NCT07177339

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

  • Boise VA Medical Center, Boise
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 22. jul. 2026 · NCT06390345

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Boise
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 9. apr. 2026 · NCT06961214

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.